Kivisäkk P - Search Results

1

Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions.

Helms G, Stawiarz L, Kivisäkk P, Link H. Helms G, et al. Among authors: kivisakk p. Magn Reson Med. 2000 Jan;43(1):102-10. doi: 10.1002/(sici)1522-2594(200001)43:1<102::aid-mrm12>3.0.co;2-i. Magn Reson Med. 2000. PMID: 10642736 Free article. Clinical Trial.

2

IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS).

Kivisäkk P, Matusevicius D, He B, Söderström M, Fredrikson S, Link H. Kivisäkk P, et al. Clin Exp Immunol. 1998 Jan;111(1):193-7. doi: 10.1046/j.1365-2249.1998.00478.x. Clin Exp Immunol. 1998. PMID: 9472681 Free PMC article.

3

Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke.

Elkarim RA, Mustafa M, Kivisäkk P, Link H, Bakhiet M. Elkarim RA, et al. Among authors: kivisakk p. Eur J Clin Invest. 1998 Apr;28(4):295-9. doi: 10.1046/j.1365-2362.1998.00279.x. Eur J Clin Invest. 1998. PMID: 9615907

4

No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.

Kivisäkk P, Teleshova N, Ozenci V, Huang Y, Matusevicius D, Fredrikson S, Söderström M, Link H. Kivisäkk P, et al. J Neuroimmunol. 1998 Nov 2;91(1-2):108-12. doi: 10.1016/s0165-5728(98)00158-1. J Neuroimmunol. 1998. PMID: 9846826

5

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

Ozenci V, Rinaldi L, Teleshova N, Matusevicius D, Kivisäkk P, Kouwenhoven M, Link H. Ozenci V, et al. Among authors: kivisakk p. J Autoimmun. 1999 Jun;12(4):297-303. doi: 10.1006/jaut.1999.0285. J Autoimmun. 1999. PMID: 10330301

6

High numbers of perforin mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions.

Kivisäkk P, Stawiarz L, Matusevicius D, Fredrikson S, Söderström M, Hindmarsh T, Link H. Kivisäkk P, et al. Acta Neurol Scand. 1999 Jul;100(1):18-24. doi: 10.1111/j.1600-0404.1999.tb00719.x. Acta Neurol Scand. 1999. PMID: 10416508

7

Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis.

Pashenkov M, Mustafa M, Kivisäkk P, Link H. Pashenkov M, et al. Among authors: kivisakk p. Scand J Immunol. 1999 Sep;50(3):302-8. doi: 10.1046/j.1365-3083.1999.00598.x. Scand J Immunol. 1999. PMID: 10447940 Free article.

8

Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis.

Kivisäkk P, Alm GV, Fredrikson S, Link H. Kivisäkk P, et al. Eur J Neurol. 2000 Jan;7(1):27-34. doi: 10.1046/j.1468-1331.2000.00002.x. Eur J Neurol. 2000. PMID: 10809912 Clinical Trial.

9

Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables.

Putheti P, Morris M, Stawiarz L, Teleshova N, Kivisäkk P, Pashenkov M, Kouwenhoven M, Wiberg MK, Bronge L, Huang YM, Söderström M, Hillert J, Link H. Putheti P, et al. Among authors: kivisakk p. Eur J Neurol. 2003 Sep;10(5):529-35. doi: 10.1046/j.1468-1331.2003.00638.x. Eur J Neurol. 2003. PMID: 12940835

10

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis.

Navikas V, Matusevicius D, Söderström M, Fredrikson S, Kivisäkk P, Ljungdahl A, Höjeberg B, Link H. Navikas V, et al. Among authors: kivisakk p. J Neuroimmunol. 1996 Jan;64(1):63-9. doi: 10.1016/0165-5728(95)00155-7. J Neuroimmunol. 1996. PMID: 8598391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters